Keywords: sclc, drug, market, wil, double, 648m, small-cell

SCLC drug market wil more than double to $648M in 2017

Article | 14 April 2009

Print This

The small-cell lung cancer drug market will more than double from just under $250.0 million in 2007 to more than $684.0 million in 2017, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in